![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/395 | (2006.01) |
A61K 39/395 | (2013.01) | ||
A61P 9/10 | (2006.01) | ||
A61K2039/505 | (2013.01) | ||
A61P 29/00 | (2006.01) | ||
C07K2317/33 | (2013.01) | ||
A61P 37/06 | (2006.01) | ||
C07K2317/76 | (2013.01) | ||
C07K2317/92 | (2013.01) | ||
C07K 16/2866 | (2013.01) | ||
A61P 37/06 | (2018.01) | ||
A61P 29/00 | (2018.01) |
(11) | Number of the document | 3283110 |
(13) | Kind of document | T |
(96) | European patent application number | 16780800.5 |
Date of filing the European patent application | 2016-04-15 | |
(97) | Date of publication of the European application | 2018-02-21 |
(45) | Date of publication and mention of the grant of the patent | 2022-04-20 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/027676 |
Date | 2016-04-15 |
(87) | Number | WO 2016/168542 |
Date | 2016-10-20 |
(30) | Number | Date | Country code |
201562147824 P | 2015-04-15 | US |
(72) |
BOWERS, Peter , US
MCKNIGHT, Andrew John , US
KING, David J. , US
LONDEI, Marco , US
|
(73) |
AnaptysBio, Inc. ,
10770 Wateridge Circle, Suite 210, San Diego, CA 92121,
US
|
(54) | ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R) |
ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R) |